A synthetic form of human parathyroid hormone, teriparatide, is more efficacious than a bisphosphonate for the treatment of glucocorticoid-induced osteoporosis (GIO), according to a multinational ...

Overall, 10 randomly selected women received teriparatide and the remaining 11 served as controls. Patients who received teriparatide had increased bone formation on both cancellous and ...

Teriparatide (recombinant) 250mcg/mL; soln for SC inj; contains m-cresol. Teriparatide stimulates new bone formation on trabecular and cortical (periosteal and/or endosteal) bone surfaces by ...

The University of Nottingham spin-out company, Critical Pharmaceuticals, has announced a £545,000 collaboration with the University to develop a nano-enabled intranasal formulation of teriparatide for ...

Forsteo (teriparatide) – a bone-building parathyroid hormone drug sold as Forteo in the US – has been a big earner for Lilly for years, although revenues have already started to fall thanks to ...

Until now, the main options for women in this category have been UCB's Evenity (romosozumab) or Eli Lilly's Forsteo (teriparatide), with older generic bisphosphonates such as alendronic acid used ...